CMI Communications

Congratulations to David Foley and the PathWest team for this important publication, especially considering the increase of syphilis in Australia

#MicroSky #IDEpi #IDSky

The utility of combined syphilis PCR and serology during an outbreak in Western Australia: A multicentre retrospective diagnostic evaluation Syphilis has re-emerged as a global public health concern. Although serology is well established, the role of PCR remains unclear. We evaluated the di…

📣 Foley et al assess #syphilis PCR & serology in >8K Australian patients

#Serology: still essential for first infections & reinfections

#PCR: limited add'l benefit in first infections; w/ serology can improve detection of reinfections

#IDSky #clinmicro #diagnosticstewardship

ow.ly/hh0M50Y5j50

CMI Comms editors Emily McDonald, Erin McCreary, Nav Narayanan, and Thomas Tängdén standing together and looking lovely. :-)

Spotted at the #CLSI meeting in Arizona: CMI Comms editors (and #Communicable hosts) @dremilymcd.bsky.social, @erinmccreary.bsky.social, Nav Narayanan, and Thomas Tängdén 🫶

Communicable | Communicable Episode 45: Top infectious diseases papers in 2025 In this episode of Communicable, Josh Davis (Newcastle, Australia) and Emily McDonald (Montreal, Canada), plus invited guest, Steven Tong (Melbourne, Australia)—all practicing physicians and clinical trialists— assemble to discuss some of their ‘top infectious diseases papers published in 2025’....

🎙️ Just published Communicable E45: Top infectious diseases papers in 2025

Hosted by Josh Davis & Emily McDonald w/ invited guest Steven Tong

Listen on #Communicable: https://share.transistor.fm/s/9e626f2a

#IDSky #clinmicro

📣 New #Communicable drops Mon 26 Jan! In our last episode, we brought you some favorite #clinmicro papers of 2025. We continue this thread in our next episode with top ID papers of 2025, picked by our editors, Josh Davis & Emily McDonald and guest, Steven Tong. ⭐ Tune in Monday🎙️

#IDSky

"Our institutions signal a clear preference for quantity over quality" ➡️ it's time to drop speedy but low-quality and weak science, and steer the weel towards robust, reliable, but slow science -aka degrowth 😊✊📉💪

#ScholarlyPublishing #AcademicPublishing #PublicationIntegrity #ResearchIntegrity

📣 New #Communicable drops Mon 26 Jan! In our last episode, we brought you some favorite #clinmicro papers of 2025. We continue this thread in our next episode with top ID papers of 2025, picked by our editors, Josh Davis & Emily McDonald and guest, Steven Tong. ⭐ Tune in Monday🎙️

#IDSky

The beating heart of a broken machine

📣 A peer reviewer used #AI to create a fake review with 6 self-citation prompts. But is s/he the only perpetrator in our system? In the year's first editorial, Angela Huttner explores the depths of the academic-industrial complex.

#IDSky #clinmicro #peerreview

https://ow.ly/juoW50Y05t6

Microbiology royalty: Elizabeth O. King and the legacy of Elizabethkingia meningoseptica The genus Elizabethkingia comprises Gram-negative, nonmotile, nonspore-forming aerobic rods in the family Weeksellaceae. These nonglucose-fermenting organisms were long included within Flavobacterium ...

📣 Who is behind #Kingella kingae, #Elizabethkingia
meningoseptica, and several other bacteria? Anne-Marie Dolan et al describe the legacy of Elizabeth O. King, #CDC microbiologist & World War II army officer, for our #Personbehindthename series.

#IDSky #clinmicro

www.cmi-comms.org/article/S295...

Pretty cool that Robin Patel picks Ouli Xie's @lancetmicrobe.bsky.social paper on SDSE and S pyogenes as one of her top 3 clinical microbiology papers for 2025! As expected, Robin does a great job explaining the paper.

www.thelancet.com/journals/lan...

@onisillos.bsky.social

🎙️ Just published Communicable E44: Top clinical microbiology papers in 2025

Hosted by Annie Joseph & Josh Nosanchuk w/ invited guests Robin Patel & Fidelma Fitzpatrick

Listen on #Communicable: https://share.transistor.fm/s/6e5c26ae

#IDSky #clinmicro

Contextualizing the use of corticosteroids in severe Pneumocystis jirovecii pneumonia through a Bayesian lens A recent multicenter randomized clinical trial (RCT) of steroids for severe Pneumocystis jirovecii pneumonia (PCP) in patients without HIV failed to demonstrate a significant benefit in its primary ou...

📣 Are steroids likely to reduce mortality in non-HIV patients with severe PCP? @drtoddlee.bsky.social, @dremilymcd.bsky.social et al. reexamine the Lemiale RCT with a Bayesian lens to find out.

#IDSky #clinmicro #PCP #immunosky #medsky

www.cmi-comms.org/article/S295...

📣 New #Communicable drops Mon 12 Jan! We kick off the new year with Annie Joseph & Josh Nosanchuk hosting Robin Patel (Mayo Clinic) & Fidelma Fitzpatrick (RCSI) to discuss their top #clinmicro papers of 2025 ⭐ Tune in Monday🎙️

#IDSky

Evidence for antibiotic durations in chronic bacterial prostatitis: A systematic review Optimal antibiotic durations for chronic bacterial prostatitis (CBP) are unknown; current guidelines recommend 4–12 weeks.To systematically review the…

📣 Systematic review by @lcordes.bsky.social, @bwtrautner.bsky.social, @merellambregts.bsky.social et al assessing evidence for long #antibiotic durations in chronic bacterial #prostatitis. Spoiler: there isn’t much.

#IDSky #clinmicro #UroSky #MedSky #OA #AMR

www.sciencedirect.com/science/arti...

An integrated surveillance study of SARS-CoV-2, influenza virus, and respiratory syncytial virus infections We aimed to describe recent epidemiological trends of SARS-CoV-2, influenza virus (A/B), and respiratory syncytial virus (RSV) in the canton of Geneva, Switzerland, using data from the Sentinella netw...

📣 #Wastewater surveillance is a powerful tool. In this integrated molecular epidemiologic study of >1000 patients with #influenza, #RSV, or #Covid, it correlates year after year with number of inpatient + ambulatory cases.

#IDSky #clinmicro #ViroSky #EpiSky #OA
www.cmi-comms.org/article/S295...

My personal favourite @cmicomms.bsky.social episode in 2025 was Ep. 29 "Bacterial Vaginosis & Male Partners".
Super fascinating science alongside someone so passionate about the science. I've even shared this ep to my non-science friends and they thought it was awesome too

One of the biggest challenges I've had coming back to "regular life" in Australia after my time with MSF is dealing with fireworks.
Fireworks in essence are just pretty coloured bombs.
Happy New Year's y'all.
May 2026 bring actual peace and security, equality and equity.

🎙️ Just published #Communicable E43: Katie's picks of 2025

Hosted by Angela Huttner & Annie Joseph w/ invited 'guest' Katie Hostettler, managing editor at CMI Communications & Communicable producer

Listen on #Communicable: https://share.transistor.fm/s/0da740f3

💡An important commentary on vaccines from ESCMID by the Vaccines Subcommittee Director, the Chair of the Vaccines Study Group & the ESCMID Executive Committee jointly published in CMI & CMI Comms.

CMI: https://ow.ly/HUGM50XNByv
CMI Comms: https://ow.ly/xmbk50XNByx

#IDSky #clinmicro

It's a fair question! It's a feature on Hootsuite 🦉

📣 New #Communicable drops Mon 29 Dec!
In this year-end special, Angela Huttner & Annie Joseph invite managing editor & Communicable producer Katie Hostettler to discuss her favorite episodes. Also, all editors share some of their highlights of the year.❄️🧣

#IDSky #clinmicro

A great discussion about science on social media by @cmicomms.bsky.social
As a scientist and the creator of the #AMR feed, I love the capacity in Bluesky to be able to easily see the science, to find similar researchers, new papers etc. X was getting too noisy for finding your people #IDSky #MedSky

Thanks for the rich discussion.

My twitter regret was that I was too meek 😆 Instead I just wrote strident editorials that got largely ignored

Fortunately my day job keeps neck deep in the literature without the need for socials 😅

Thanks for this feedback. Grateful to @germhuntermd.bsky.social, @drneilstone.bsky.social, and @aetiology.bsky.social for having us see different sides.

#IDSky @angelahuttner.bsky.social @marcbonten.bsky.social

Communicable E42: Should doctors stay at X (Twitter) or leave it? During the COVID-19 pandemic with lockdown mandates and social...

🎙️ Just published: Communicable E42...

Hosted by @angelahuttner.bsky.social & @marcbonten.bsky.social

w/ invited guests Ilan Schwartz @germhuntermd.bsky.social, Neil Stone @drneilstone.bsky.social & Tara Smith @aetiology.bsky.social

Listen on #Communicable:

#IDSky #Clinmicro #IDTwitter

One of my favorite podcast 🫶 let's have a look 👀 next monday !

📣 New #Communicable drops Mon 15 Dec!
@angelahuttner.bsky.social & @marcbonten.bsky.social invite Ilan Schwartz @germhuntermd.bsky.social , Neil Stone @drneilstone.bsky.social & Tara Smith @aetiology.bsky.social to debate staying on or leaving Twitter for alternatives 🎤

#IDTwitter #IDSky #clinmicro

Community human-to-human transmission of multidrug-resistant Enterobacterales in high-income countries: A systematic review Multidrug-resistant Enterobacterales (MDRE) are widespread globally, representing a major health burden [1–3]. In recent years, faecal carriage of MDRE, namely extended-spectrum β-lactamase producing ...

📣 Systematic review on ESBL+ #Enterobacterales in HIC community dwellers over time:

Median prevalence in 2002 was 3% but now is 19%
8-37% of family members become #ESBL carriers
Few data on interventions to prevent community transmission

#IDSky #clinmicro #MedSky
www.cmi-comms.org/article/S295...

🔥Community human-to-human transmission of multidrug resistant Enterobacterales in high-income countries: a systematic review @cmicomms.bsky.social @escmid.bsky.social @esgap.bsky.social

kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F...

Breaking down the Desirability of Outcome Ranking (DOOR): unpacking the methodology behind the Dalbavancin as an Option for Treatment of Staphylococcus aureus Bacteremia (DOTS) trial Desirability of Outcome Ranking (DOOR) outcomes such as the primary outcome of the DOTS (Dalbavancin as an Option for Treatment of Staphylococcus aure…

🤔 I’ll admit — I’m still wrapping my head around DOOR in clinical trials. I’m used to P-values and classic non-inferiority, but DOOR feels different.
Breaking down the DOOR in DOTS RCT @cmicomms.bsky.social
#idsky #EMIMCC
www.sciencedirect.com/science/arti...